About Axiom
Methodology, not opinion.
Axiom Longevity exists to solve a specific problem: the gap between having biological data and knowing what to do with it.
The Premise
You probably have enough data already.
What you lack is a framework.
Most people who invest seriously in their health reach a point where the data outpaces the strategy. The DNA panel sits in one portal. The bloodwork in another. The supplement stack grows. The recommendations conflict. The signal gets lost in the noise.
Axiom was built to address that exact moment. Not by adding more data, but by integrating what already exists into a single intelligence model that tells you what matters, what does not, and what to do next.
We are not a clinic. We are not a supplement company. We are not a wellness brand. We are a strategy firm that operates at the intersection of genomics, biomarker science, and applied longevity practice.
The Methodology
Every recommendation traces back to data.
Our process is built on three principles that define how we work with every client.
Integration Over Accumulation
More tests do not create more clarity. We take what you already have and cross reference it into a unified model. DNA informs biomarker context. Biomarkers inform protocol design. Everything connects.
Prioritization Over Volume
We identify the five highest leverage intervention areas for your biology and focus there. Reducing unnecessary complexity is often the single most valuable thing we do.
Strategy Over Prescription
We do not tell you what supplements to take. We build a strategic framework that lets you make decisions with confidence, adapt to new data, and refine your approach over time.
The Founder
Diego Pauel
Founder and Principal Strategist
Diego founded Axiom after recognizing a pattern across the health conscious executives he advised: they had invested significantly in diagnostics and testing, but lacked a unified strategy that connected the data to meaningful action. That methodology now powers the longevity intelligence programs offered by luxury wellness properties worldwide.
His work sits at the intersection of business strategy and biological science. He combines deep knowledge of genomic risk profiling, clinical biomarker analysis, and evidence based protocol design into a single methodology that prioritizes clarity over complexity. Every client engagement reflects years of studying how genetic variants interact with biomarker patterns, how metabolic signals compound over time, and how to translate those findings into protocols that people actually follow.
Diego designed the Axiom methodology and oversees every property partnership. The analytical framework, report structure, and quality standards reflect years of refining how genetic variants interact with biomarker patterns, how metabolic signals compound over time, and how to translate those findings into protocols that guests actually follow.
1:1
Every client works
directly with Diego
40-60
Pages per strategic
intelligence report
90
Days to measurable
biomarker improvement
100%
Client key marker
improvement rate
Areas of Expertise
• SNP and whole genome interpretation for longevity risk stratification
• Comprehensive biomarker analysis beyond standard reference ranges
• Metabolic health, insulin resistance, and cardiovascular risk profiling
• Methylation pathway analysis and MTHFR variant interpretation
• Hormonal resilience assessment including DHEA S and cortisol mapping
• Evidence based supplement protocol design and stack optimization
Approach to Practice
Diego does not follow trends, sell products, or promote protocols based on popularity. Every recommendation traces back to peer reviewed research, contextualized to the individual. If the evidence does not support an intervention for a specific client, it does not enter the protocol, regardless of how widely it is recommended elsewhere.
This philosophy extends to what Axiom removes from a client's routine. Supplement stacks are routinely reduced by 40 to 60 percent. Unnecessary tests are identified and eliminated. The goal is not more, but better. Fewer interventions, higher precision, clearer priorities.
Founding Principle
"We do not guess. We do not follow trends. We interpret data, prioritize risk, and build strategy."
"Longevity is not a trend. It is a long term design process."